{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:49:56Z","timestamp":1791985796764,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKEN","doi-asserted-by":"crossref","award":["15K20292"],"award-info":[{"award-number":["15K20292"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00417-022-05827-y","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T11:06:13Z","timestamp":1662721573000},"page":"833-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Risk factors for development of superior limbic keratoconjunctivitis in thyroid eye disease in Japanese"],"prefix":"10.1007","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1363-2870","authenticated-orcid":false,"given":"Yasuhiro","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aric","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohiko","family":"Kakizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"key":"5827_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.survophthal.2021.05.009","volume":"67","author":"S Lahoti","year":"2022","unstructured":"Lahoti S, Weiss M, Johnson DA, Kheirkhah A (2022) Superior limbic keratoconjunctivitis: a comprehensive review. Surv Ophthalmol 67:331\u2013341","journal-title":"Surv Ophthalmol"},{"key":"5827_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s10792-017-0588-1","volume":"38","author":"A Rodriguez-Garcia","year":"2018","unstructured":"Rodriguez-Garcia A, Macias Rodriguez Y, Gonzalez-Gonzalez JM (2018) Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis. Int Ophthalmol 38:1243\u20131249","journal-title":"Int Ophthalmol"},{"key":"5827_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/eye.1989.26","volume":"3","author":"JD Nelson","year":"1989","unstructured":"Nelson JD (1989) Superior limbic keratoconjunctivitis (SLK). Eye 3:180\u2013189","journal-title":"Eye"},{"key":"5827_CR4","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/S0161-6420(95)30843-3","volume":"102","author":"EF Kadrmas","year":"1995","unstructured":"Kadrmas EF, Bartley GB (1995) Superior limbic keratoconjunctivitis: a prognostic sign for severe Graves ophthalmopathy. Ophthalmology 102:1472\u20131475","journal-title":"Ophthalmology"},{"key":"5827_CR5","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jfma.2013.10.003","volume":"114","author":"YH Wei","year":"2015","unstructured":"Wei YH, Chen WL, Hu FR, Liao SL (2015) In vivo confocal microscopy of bulbar conjunctiva in patients with Graves\u2019 ophthalmopathy. J Formos Med Assoc 114:965\u2013972","journal-title":"J Formos Med Assoc"},{"key":"5827_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1001\/archopht.1969.00990020582002","volume":"82","author":"I Char","year":"1969","unstructured":"Char I (1969) Clinical features of superior limbic keratoconjunctivitis in Australia. Arch Ophthalmol 82:580\u2013586","journal-title":"Arch Ophthalmol"},{"key":"5827_CR7","first-page":"467","volume":"9","author":"E Chelala","year":"2015","unstructured":"Chelala E, Rami HE, Dirani A, Fakhoury H, Fadlallah A (2015) Extensive superior limbic keratoconjunctivitis in Graves\u2019 disease: case report and mini-review of the literature. Clin Ophthalmol 9:467\u2013468","journal-title":"Clin Ophthalmol"},{"key":"5827_CR8","first-page":"555","volume":"92","author":"P Wright","year":"1972","unstructured":"Wright P (1972) Superior limbic keratoconjunctivitis. Trans Ophthalmol Soc UK 92:555\u2013560","journal-title":"Trans Ophthalmol Soc UK"},{"key":"5827_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00004397-198602640-00010","volume":"26","author":"FM Wilson II","year":"1986","unstructured":"Wilson FM II, Ostler HB (1986) Superior limbic keratoconjunctivitis. Int Ophthalmol Clin 26:99\u2013112","journal-title":"Int Ophthalmol Clin"},{"key":"5827_CR10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0021-5155(01)00407-5","volume":"45","author":"Y Murakami","year":"2001","unstructured":"Murakami Y, Kanamoto T, Tsuboi T, Maeda T, Inoue Y (2001) Evaluation of extraocular muscle enlargement in dysthyroid ophthalmopathy. Jpn J Ophthalmol 45:622\u2013627","journal-title":"Jpn J Ophthalmol"},{"key":"5827_CR11","first-page":"965","volume":"54","author":"N Nakashima","year":"2003","unstructured":"Nakashima N, Maeda T, Inoue T, Inoue Y (2003) Clinical study of superior limbic keratoconjunctivitis associated with dysthyroid ophthalmopathy. Folia Ophthalmol Jpn 54:965\u2013968 (Japanese)","journal-title":"Folia Ophthalmol Jpn"},{"key":"5827_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/01676830.2020.1814352","volume":"40","author":"C Lo","year":"2021","unstructured":"Lo C, Yang M, Rootman D (2021) Natural history of inflammatory and non-inflammatory dry eye in thyroid eye disease. Orbit 40:389\u2013393","journal-title":"Orbit"},{"key":"5827_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ajo.2013.12.027","volume":"157","author":"Y Takahashi","year":"2014","unstructured":"Takahashi Y, Ichinose A, Kakizaki H (2014) Topical rebamipide treatment for superior limbic keratoconjunctivitis in patients with thyroid eye disease. Am J Ophthalmol 157:807\u2013812","journal-title":"Am J Ophthalmol"},{"key":"5827_CR14","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1038\/s41598-021-84661-4","volume":"11","author":"Y Takahashi","year":"2021","unstructured":"Takahashi Y, Lee PAL, Vaidya A, Kono S, Kakizaki H (2021) Tear film break-up patterns in thyroid eye disease. Sci Rep 11:5288","journal-title":"Sci Rep"},{"key":"5827_CR15","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.3390\/jcm10163687","volume":"10","author":"Y Takahashi","year":"2021","unstructured":"Takahashi Y, Vaidya A, Kakizaki H (2021) Changes in eyelid pressure and dry eye status after orbital decompression in thyroid eye disease. J Clin Med 10:3687","journal-title":"J Clin Med"},{"key":"5827_CR16","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.3390\/jcm9092814","volume":"9","author":"S Inoue","year":"2020","unstructured":"Inoue S, Kawashima M, Arita R, Kozaki A, Tsubota K (2020) Investigation of meibomian gland function and dry eye disease in patients with Graves\u2019 ophthalmopathy. J Clin Med 9:2814","journal-title":"J Clin Med"},{"key":"5827_CR17","first-page":"57","volume":"9","author":"JH Selter","year":"2015","unstructured":"Selter JH, Gire AI, Sikder S (2015) The relationship between Graves\u2019 ophthalmopathy and dry eye syndrome. Clin Ophthalmol 9:57\u201362","journal-title":"Clin Ophthalmol"},{"key":"5827_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.beem.2011.11.009","volume":"26","author":"W M\u00fcller-Forell","year":"2012","unstructured":"M\u00fcller-Forell W, Kahaly GJ (2012) Neuroimaging of Graves\u2019 orbitopathy. Best Pract Res Clin Endocrinol Metab 26:259\u2013271","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"5827_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00417-018-4197-0","volume":"257","author":"E Ishikawa","year":"2019","unstructured":"Ishikawa E, Takahashi Y, Valencia MRP, Ana-Magadia MG, Kakizaki H (2019) Asymmetric lacrimal gland enlargement: an indicator for detection of pathological entities other than thyroid eye disease. Graefes Arch Clin Exp Ophthalmol 257:405\u2013411","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5827_CR20","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s40618-020-01258-w","volume":"43","author":"P Perros","year":"2020","unstructured":"Perros P, \u017darkovi\u0107 MP, Panagiotou GC, Azzolini C, Ayvaz G, Baldeschi L, Bartalena L, Boschi AM, Nardi M, Brix TH, Covelli D, Daumerie C, Eckstein AK, Fichter N, \u0106iri\u0107 S, Heged\u00fcs L, Kahaly GJ, Konuk O, Lareida JJ, Okosieme OE, Leo M, Mathiopoulou L, Clarke L, Menconi F, Morris CM, Orgiazzi J, Pitz S, Salvi M, Muller I, Kne\u017eevic M, Wiersinga WM, Curr\u00f2 N, Dayan CM, Marcocci C, Marin\u00f2 M, M\u00f6ller L, Pearce SH, T\u00f6r\u00fcner F, Bernard M, The European Group on Graves\u2019 Orbitopathy (2020) Asymmetry indicates more severe and active disease in Graves\u2019 orbitopathy: results from a prospective cross-sectional multicentre study. J Endocrinol Invest 43:1717\u20131722","journal-title":"J Endocrinol Invest"},{"key":"5827_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1046\/j.1365-2265.1996.8220832.x","volume":"45","author":"J Pfeilschifter","year":"1996","unstructured":"Pfeilschifter J, Ziegler R (1996) Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol (Oxford) 45:477\u2013481","journal-title":"Clin Endocrinol (Oxford)"},{"key":"5827_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/00002341-199306000-00001","volume":"9","author":"WR Nunery","year":"1993","unstructured":"Nunery WR, Martin RT, Heinz GW, Gavin TJ (1993) The association of cigarette smoking with clinical subtypes of ophthalmic Graves\u2019 disease. Ophthalmic Plast Reconstr Surg 9:77\u201382","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"5827_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/bjo.73.8.639","volume":"73","author":"MP Mourits","year":"1989","unstructured":"Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: a novel approach. Br J Ophthalmol 73:639\u2013644","journal-title":"Br J Ophthalmol"},{"key":"5827_CR24","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.ophtha.2007.07.027","volume":"115","author":"RV Gaddipati","year":"2008","unstructured":"Gaddipati RV, Meyer DR (2008) Eyelid retraction, lid lag, lagophthalmos, and von Graefe\u2019s sign quantifying the eyelid features of Graves\u2019 ophthalmopathy. Ophthalmology 115:1083\u20131088","journal-title":"Ophthalmology"},{"key":"5827_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000475947","volume-title":"Graves\u2019 orbitopathy: a multidisciplinary approach \u2013 questions and answers","author":"MC Burlacu","year":"2017","unstructured":"Burlacu MC, Daumerie C (2017) Epidemiology. In: Wiersinga WM, Kahaly GJ (eds) Graves\u2019 orbitopathy: a multidisciplinary approach \u2013 questions and answers. Karger, Basel, pp 33\u201340"},{"key":"5827_CR26","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1136\/bjo.86.12.1347","volume":"86","author":"AJ Lee","year":"2002","unstructured":"Lee AJ, Lee J, Saw SM, Gazzard G, Koh D, Widjaja D, Tan DTH (2002) Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol 86:1347\u20131351","journal-title":"Br J Ophthalmol"},{"key":"5827_CR27","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s00417-015-3156-2","volume":"253","author":"GJ Ben Simon","year":"2015","unstructured":"Ben Simon GJ, Katz G, Zloto O, Leiba H, Hadas B, Huna-Baron R (2015) Age differences in clinical manifestation and prognosis of thyroid eye disease. Graefes Arch Clin Exp Ophthalmol 253:2301\u20132308","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5827_CR28","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1097\/SCS.0000000000006442","volume":"31","author":"S Kakutani","year":"2020","unstructured":"Kakutani S, Ito M, Kakizaki H, Takahashi Y (2020) Orbital decompression for exorbitism and exophthalmos in a patient with thyroid eye disease. J Craniofac Surg 31:e477\u2013e479","journal-title":"J Craniofac Surg"},{"key":"5827_CR29","first-page":"9514279","volume":"2021","author":"D Li","year":"2021","unstructured":"Li D, Sun F (2021) Observations on the efficacy of two methods for the treatment of upper eyelid retraction in thyroid-associated ophthalmopathy. Biomed Res Int 2021:9514279","journal-title":"Biomed Res Int"},{"key":"5827_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-022-05575-z","author":"C Cheng","year":"2022","unstructured":"Cheng C, Zhu M, Lin T, Chen Z, Zeng W, Li K, Xue R, Duan F, Wu K (2022) Recharacterization of superior limbic keratoconjunctivitis via a subdividing grading method in 236 Chinese patients. Graefes Arch Clin Exp Ophthalmol. https:\/\/doi.org\/10.1007\/s00417-022-05575-z (Online ahead of print)","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05827-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05827-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05827-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T19:41:41Z","timestamp":1701027701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05827-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["5827"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05827-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,9]]},"assertion":[{"value":"5 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board (IRB) of Aichi Medical University Hospital (No. 2021\u2013176). This study including human participants was also conducted in accordance with the tenets of the Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The IRB granted a waiver of informed consent for this study based on the ethical guidelines for medical and health research involving human subjects established by the Japanese Ministry of Education, Culture, Sports, Science, and Technology; and by the Ministry of Health, Labour, and Welfare. The waiver was granted because the study was not an interventional study. Nevertheless, at the request of the IRB, we published an outline of the study on the Aichi Medical University website to give patients the opportunity to refuse to participate in the study, although none did. Personal identifiers were removed from the records prior to data analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}